Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma

NCT02054130 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

584

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Placebo
DRUG: MEDI9929 70 mg
DRUG: MEDI9929 210 mg
DRUG: MEDI9929 280 mg

Sponsor

MedImmune LLC

Collaborators

[object Object]